The Trump administration had an opening. The hemp market proved the concept. The polling supported the move. The fiscal argument was there. Instead, the White House published a 195-page document that reads like it was written in 1988, invokes psychosis studies with contested methodology, and affirms the recriminalization of a $28 billion industry that was, by any reasonable measure, working.

Medical marijuana is becoming increasingly mainstream across the United States, with millions of patients now using cannabis to manage conditions such as chronic pain, anxiety, PTSD, insomnia, epilepsy, and cancer-related symptoms. But as legalization expands and dispensaries become easier to access, an important issue is getting lost in the excitement: physician guidance still matters.

Start with the most obvious one. The pharmaceutical industry loses, by some estimates, around $10 billion annually in markets where medical cannabis is legal. Patients substitute cannabis for opioids, sleep aids, anti-anxiety medications, and antidepressants. Not all patients, and not always — but enough to show up in the revenue reports.

The 2026 awards made one thing clear: growers are done with mystery clones from anonymous sellers. Get Seeds Right Here earned #1 because it gave growers the strongest overall package: catalog, reputation, ordering experience, and a clear long-term commitment to the cannabis clone space. The rest of the top five earned their spots doing the same work at a slightly smaller scale.

Chinese researchers at Shandong University just published a study in the Journal of Archaeological Science that does something straightforward: it tells the truth about cannabis's place in human history. Using phytolith analysis — the study of microscopic plant silica structures found in soil — the team examined 132 samples from two Late Neolithic settlements in the Shandong province. What they found was not marginal or incidental. Cannabis was one of the five grains.

So, are cannabis pens gaining ground in North America? The overall trend says yes. However, a more insightful question is why they are becoming more popular and what this reveals about the future of legal cannabis.

This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the cannabis industry wants to talk about openly—because acknowledging it means acknowledging that the "professionalization" of weed has, in many respects, destroyed the thing that made it worth professionalizing.

The petrochemical industry that grew in hemp's absence now generates revenues in the tens of trillions annually across its downstream product chains—plastics, synthetic fibers, lubricants, paints, solvents, packaging, insulation, construction materials.

In the rapidly evolving world of cannabis, information is the most valuable currency. For years, platforms like Cannabis.net have served as the ultimate hub for enthusiasts, patients, and industry professionals to stay informed about legalization, medical breakthroughs, and market trends

Every two years, cannabis advocates wheel out the same ritual. Ballot measures, candidate endorsements, grasstops lobbying, NORML scorecards, press releases about historic progress. Every two years, a version of the same headline runs: "Cannabis Reform Reaches Tipping Point." Every two years, the people who believed it discover that the tipping point was a marketing event.